Table 3.
Drug-Related Adverse Events Observed in More Than One Patient
| Adverse Event* | Prandial State |
||
|---|---|---|---|
| Fasted Overnight (n = 27) | Low-Fat Breakfast (n = 26) | High-Fat Breakfast (n = 27) | |
| Diarrhea with all doses | |||
| Grades 1 and 2 | |||
| No. | 6 and 1 | 5 and 1 | 9 and 0 |
| % | 22 and 4 | 19 and 4 | 33 and 0 |
| Onset, days | |||
| Median | 0 | 0 | 0.5 |
| Range | 0–2 | 0–1 | 0–2 |
| Duration, days | |||
| Median | 2 | 3.5 | 2 |
| Range | 1–44 | 1–29 | 1–65 |
| Diarrhea with first dose only | |||
| Grades 1 and 2 | |||
| No. | 3 and 0 | 2 and 0 | 3 and 0 |
| % | 11 and 0 | 8 and 0 | 11 and 0 |
| Onset, days | |||
| Median | 0 | 0.5 | 1 |
| Range | 0–1 | 0–1 | 0–1 |
| Duration, days | |||
| Median | 2 | 2.5 | 2 |
| Range | 2–44 | 1–4 | 1–65 |
| Nausea | |||
| Grade 1 | |||
| No. | 5 | 1 | 2 |
| % | 19 | 4 | 7 |
| Fatigue | |||
| Grade 1 | |||
| No. | 3 | 1 | 1 |
| % | 11 | 4 | 4 |
| Rash | |||
| Grades 1 and 3 | |||
| No. | 1 and 0 | 1 and 0 | 0 and 1 |
| % | 4 and 0 | 4 and 0 | 0 and 4 |
Adverse events are categorized by severity, onset, and duration. Onset measured relative to preceding dose; duration measured relative to onset. Adverse events severity measured by National Cancer Institute Common Toxicity Criteria.